CHARLES PARK: Open Payments
NPI 1235214131 · LONE TREE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 29 payments from 11 companies in 2025. Trend: 2023 $163 · 2024 $251 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $183 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| Indivior Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $62 |
| Bausch Health US, LLC | 2 | $36 |
| Alkermes, Inc. | 2 | $31 |
| Braeburn Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, REXULTI, SUBLOCADE, INGREZZA, BRIXADI, ABILIFY ASIMTUFII, TRINTELLIX, CAPLYTA.
Industry payments across CO — which companies pay providers there.
